Table 1 Baseline characteristics of the subjects (males, n = 39)
mean ± SEM (%) | range | |
|---|---|---|
Age (years) | 52 ± 1 | (35-74) |
Body mass index (kg/m2) | 27.8 ± 0.6 | (20.2-40.3) |
Neck circumference (cm) | 40 ± 0.4 | (36-46) |
Waist circumference (cm) | 95 ± 1 | (80-114) |
Hip circumference (cm) | 100 ± 1 | (90-116) |
Total fat area (cm2) | 330 ± 35 | (86-1313) |
Visceral fat area (cm2) | 163 ± 31 | (22-1117) |
Subcutaneous fat area (cm2) | 167 ± 9 | (64-312) |
Smoking (none-/ex-/current-smoker) | 13/14/12 | |
Systolic blood pressure (mmHg) | 131 ± 2 | (100-160) |
Diastolic blood pressure (mmHg) | 82 ± 2 | (58-108) |
Fasting blood glucose (mg/dL) | 80 ± 3 | (61-124) |
Fasting immunoreactive insulin (μIU/mL) | 11 ± 1 | (3-26) |
Triglyceride (mg/dL) | 158 ± 12 | (52-375) |
High-density lipoprotein-cholesterol (mg/dL) | 49 ± 2 | (33-100) |
Low-density lipoprotein-cholesterol (mg/dL) | 133 ± 3 | (97-171) |
Diabetes mellitus/Hypertension/Dyslipidemia | 3/28/28 | |
Metabolic syndrome | 16 (41) | |
Epworth Sleepiness Scale | 13 ± 1 | (2-23) |
Cardiorespiratory monitoring findings | ||
Apnea-hypopnea index (AHI) (events/hour) | 39 ± 4 | (8.2-116.6) |
Baseline SpO2 (%) | 98 ± 0.1 | (97-100) |
Lowest SpO2 (%) | 72 ± 2 | (33-91) |
4% oxygen desaturation index (events/hour) | 27 ± 3 | (1.4-91.1) |
% < 90% time | 7 ± 2 | (0-51.4) |
Apnea-hypopnea index (AHI) ≥ 5 to < 15 (mild) | 7 | |
≥ 15 to < 30 (moderate) | 11 | |
≥ 30 (severe) | 21 | |
Computed tomography scan findings | ||
< 50% stenosis of coronary arteries | 33 (75) | |
≥ 50% stenosis of coronary arteries | 6 (15) | |
Serum high-sensitive C-reactive protein (hsCRP) (ng/dL) | 2131 ± 830 | (96-29100) |
Serum thiobarbituric acid reactive substance (TBARS), nmol/mL | 5.5 ± 0.2 | (2.7-8.0) |
Serum adiponectin (μg/mL) | 5.6 ± 0.5 | (2.1-11.8) |